Osteonecrosis of the jaw and biomarkers: What do we tell our patients?

International Journal of Oral and Maxillofacial Implants

Volumn 23, Issue 2, 2008, Pages 179-180

  Koka, Sreenivas ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

BLOOD; BONE NECROSIS; CHEMICALLY INDUCED DISORDER; EDITORIAL; HUMAN; JAW DISEASE;

BIOLOGICAL MARKERS; BONE DENSITY CONSERVATION AGENTS; COLLAGEN TYPE I; DIPHOSPHONATES; HUMANS; JAW DISEASES; OSTEONECROSIS; PEPTIDES;

EID: 43149104966     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (1)

1. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTx testing, prevention and treatment. J Oral Maxillofac Surg 2007;65:2397-2410.